[Model building in pharmacokinetics/Part III: Simplified rules for the deduction of analytical solutions for linear compartment models (author's transl)]
- PMID: 577858
[Model building in pharmacokinetics/Part III: Simplified rules for the deduction of analytical solutions for linear compartment models (author's transl)]
Abstract
Analytical solutions for any linear compartment model are obtained empirically by use of simple rules. Set up of differential equations and tedious integration procedures are thus avoided. The procedure is suited for automation by a calculator. Integrated equations are accessible then even more simply and rapidly.
Similar articles
-
[Model building in pharmacokinetics/Part II: Generalized theoretical presentation of complete integration of linear compartment models of optional structure (author's transl)].Arzneimittelforschung. 1977;27(4a):900-4. Arzneimittelforschung. 1977. PMID: 577857 German.
-
[Model building in pharmacokinetics/Part IV: Derivation of microconstants in linear compartment models (author's transl)].Arzneimittelforschung. 1977;27(4a):912-28. Arzneimittelforschung. 1977. PMID: 577859 German. No abstract available.
-
[Model building in pharmacokinetics/Part I: General strategy (author's transl)].Arzneimittelforschung. 1977;27(4a):897-900. Arzneimittelforschung. 1977. PMID: 577856 German.
-
Pharmacokinetic and pharmacodynamic modeling in vivo.Crit Rev Bioeng. 1981;5(4):273-322. Crit Rev Bioeng. 1981. PMID: 7023829 Review.
-
[Pharmacokinetics as a basic pharmacological problem].Acta Diabetol Lat. 1969 Sep;6 Suppl 1:59-73. Acta Diabetol Lat. 1969. PMID: 4906026 Review. Multiple languages. No abstract available.
Cited by
-
The pharmacokinetics and metabolism of mitoxantrone in man.Invest New Drugs. 1985;3(2):109-16. doi: 10.1007/BF00174157. Invest New Drugs. 1985. PMID: 4019115
-
Correlation between the pharmacokinetics and pharmacodynamics of dopamine in healthy subjects.Eur J Clin Pharmacol. 1984;26(2):163-9. doi: 10.1007/BF00630281. Eur J Clin Pharmacol. 1984. PMID: 6723754
-
Unaltered pharmacokinetics after the administration of high-dose etoposide without prior dilution.Cancer Chemother Pharmacol. 1991;28(3):214-6. doi: 10.1007/BF00685512. Cancer Chemother Pharmacol. 1991. PMID: 1855278
-
AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity.Int J Hematol. 2008 Nov;88(4):381-386. doi: 10.1007/s12185-008-0171-7. Epub 2008 Oct 4. Int J Hematol. 2008. PMID: 18836794
-
Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolites.Cancer Chemother Pharmacol. 1987;20(3):248-52. doi: 10.1007/BF00570495. Cancer Chemother Pharmacol. 1987. PMID: 3315284